FDA Investigator Thomas W Garvin
Thomas W Garvin has inspections in 1 countries as of 18 Aug 2023. Thomas W Garvin has collaborated with a combined 877 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
72
Last Inspection Date:
18 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron L Dunbar,
Alecia L Marson,
Amanda Dinaro,
Amos,
Andrew Saunders,
Benjamin W Anderson,
Boun M Xiong,
Catherine M Vanderhoef,
Christina A Castineyra,
Como,
Constance Lrichard Math,
Corey K Reno,
Denise L Burosh,
Diane T Reindl,
Edward E Lockwood (EEL),
Emmanuel A Dimaano, Jr,
Eric A Breselow,
Eric C Fox,
George T Allen, Jr,
Jaclyn N Munsch,
Jamie R Thompson,
Jean M Bosenbecker,
Jeffry A Bernhardt,
Jennifer Guttuso,
Jennifer S Ness,
Jesse P Romenesko,
Joel D Hustedt,
Karen R Smallwood,
Kia L Copeland,
Kimberly Lewandowski Walker,
Lisa M Lopez,
M Patriciaurphy Murphy,
Mary P Murphy,
Melissa J Holz,
Michael E Cimaglio,
Michelle J Glembin,
Mpris Inspector,
Peter R Lenahan,
Rachel T Evans,
Rafael A Kaup,
Richard Jay Tucker, RS,
Robert E Davis,
Sarah A Palmer,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Susan M Miller,
Tania E Vizcaino,
Toni S Sturgis,
Tracy North
Thomas W Garvin's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2003 | FDA 483 Response | Aspen Medical Group - Form 483R, 2003-02-10 |
January, 2003 | EIR | Aspen Medical Group - EIR, 2003-01-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more